Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 15, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 18, 2026
CEOOther
Context
Classification
other
Code D — not an open-market trade
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000914190-26-000122
Filed / recorded
Aug 18, 2026, 9:14 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BIO-TECHNE Corp
Issuer CIK
842023
Ticker
TECH
Reporting person
Kim Kelderman
Relationship
Director, Officer
Officer title
Chief Executive Officer
Security
Performance Stock Options (Right to Buy)
Table
Derivative (Table II)
Transaction date
Aug 15, 2026
Transaction code
D
Shares / units
22,389
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
1,492
Ownership form
Direct
Amendment
No
Footnotes from the filing
On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited.